Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China · Delayed Price · Currency is CNY 18.82
-0.63 (-3.24%)
Dec 29, 2025, 4:00 PM EST
SHE:301408 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 186.5 | 137.7 | 114.67 | 160.78 | 69.73 | 88.92 | Upgrade |
Depreciation & Amortization | 291.11 | 291.11 | 208.75 | 164.52 | 160.66 | 8.43 | Upgrade |
Other Amortization | 25.05 | 25.05 | 31.19 | 53.35 | 55.68 | 50.85 | Upgrade |
Loss (Gain) From Sale of Assets | -2.72 | -2.72 | -1.04 | -0.61 | -0.19 | -0.17 | Upgrade |
Asset Writedown & Restructuring Costs | 17.21 | 17.21 | -0 | 0.01 | -2.72 | -2.27 | Upgrade |
Loss (Gain) From Sale of Investments | -1.62 | -1.62 | -0.8 | -0.81 | -0.83 | -0.59 | Upgrade |
Provision & Write-off of Bad Debts | -0.08 | -0.08 | 2.26 | 1.03 | 4.39 | 4.57 | Upgrade |
Other Operating Activities | 210.37 | 63.02 | 42.74 | 34.81 | 26.46 | 8.89 | Upgrade |
Change in Accounts Receivable | 13.1 | 13.1 | -342.08 | -409.81 | -133.86 | -153.43 | Upgrade |
Change in Inventory | -17.15 | -17.15 | -179.11 | -113.01 | -131.01 | -73.81 | Upgrade |
Change in Accounts Payable | 50.72 | 50.72 | 263.8 | 288.64 | 100.41 | 97.48 | Upgrade |
Change in Other Net Operating Assets | - | - | - | 1.7 | 0.25 | 2.62 | Upgrade |
Operating Cash Flow | 767.9 | 571.76 | 131.37 | 173.84 | 140.82 | 29.33 | Upgrade |
Operating Cash Flow Growth | 252.32% | 335.22% | -24.43% | 23.45% | 380.05% | -68.15% | Upgrade |
Capital Expenditures | -130.22 | -163.42 | -221.01 | -104.77 | -33.91 | -55.32 | Upgrade |
Sale of Property, Plant & Equipment | 2.09 | 2.2 | 5.65 | 0.5 | 0 | 2.8 | Upgrade |
Cash Acquisitions | -601.69 | -329.33 | -508.68 | -3.49 | -37.54 | -0.23 | Upgrade |
Investment in Securities | 71.37 | -1.83 | -82.92 | -16.77 | 17.11 | 21.1 | Upgrade |
Other Investing Activities | 8.7 | 5.44 | 1.14 | -5.43 | 14.25 | -3.6 | Upgrade |
Investing Cash Flow | -649.75 | -486.95 | -805.82 | -129.96 | -40.09 | -35.25 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 153 | Upgrade |
Long-Term Debt Issued | - | 509.49 | 885.56 | 341.9 | 160.76 | - | Upgrade |
Total Debt Issued | 544.58 | 509.49 | 885.56 | 341.9 | 160.76 | 153 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -201.5 | Upgrade |
Long-Term Debt Repaid | - | -850.95 | -605 | -302.86 | -279.04 | - | Upgrade |
Total Debt Repaid | -630.14 | -850.95 | -605 | -302.86 | -279.04 | -201.5 | Upgrade |
Net Debt Issued (Repaid) | -85.56 | -341.45 | 280.57 | 39.05 | -118.28 | -48.5 | Upgrade |
Issuance of Common Stock | - | - | 974.56 | - | - | 111.67 | Upgrade |
Common Dividends Paid | -56.72 | -55.98 | -14.69 | -4.13 | -4.34 | -6.91 | Upgrade |
Other Financing Activities | -82.72 | 41.67 | -104.17 | -2.76 | 19 | -29.64 | Upgrade |
Financing Cash Flow | -225 | -355.77 | 1,136 | 32.15 | -103.62 | 26.62 | Upgrade |
Foreign Exchange Rate Adjustments | 0.12 | 0.11 | 0.1 | - | - | - | Upgrade |
Net Cash Flow | -106.73 | -270.84 | 461.92 | 76.04 | -2.89 | 20.7 | Upgrade |
Free Cash Flow | 637.68 | 408.33 | -89.64 | 69.07 | 106.91 | -25.99 | Upgrade |
Free Cash Flow Growth | 7433.87% | - | - | -35.40% | - | - | Upgrade |
Free Cash Flow Margin | 12.37% | 9.01% | -2.36% | 2.12% | 4.57% | -1.35% | Upgrade |
Free Cash Flow Per Share | 1.57 | 1.01 | -0.23 | 0.20 | 0.32 | -0.08 | Upgrade |
Cash Interest Paid | 0 | 0 | 0 | - | - | - | Upgrade |
Cash Income Tax Paid | 59.54 | 210.18 | 186.5 | 151.26 | 106.53 | 118.1 | Upgrade |
Levered Free Cash Flow | 315.83 | 450.85 | 214.5 | 132.02 | 228.23 | 2.7 | Upgrade |
Unlevered Free Cash Flow | 334.11 | 470.95 | 232.66 | 146.63 | 243.24 | 6.95 | Upgrade |
Change in Working Capital | 42.09 | 42.09 | -266.37 | -239.23 | -172.35 | -129.29 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.